Abstract
Purpose
Cystic fibrosis (CF) is a multisystem genetic disease caused by dysfunction of the epithelial anionic channel Cystic Fibrosis Transmembrane conductance Regulator (CFTR). Decreased mucociliary clearance because of thickened mucus is part of the pulmonary disease pathophysiology. It is controversial if the thickened airway surface liquid (ASL) is caused by the deficient chloride secretion and excessive sodium (through ENaC) and water hyperabsorption from the periciliar fluid or by the lack of bicarbonate secretion with relative acidification of the ASL. Correlations between the magnitude of in vivo chloride conductance with phenotypic characteristics and CF genotype can help to elucidate these mechanisms and direct to new treatments.
Methods
Nasal potential difference was measured in 28 CF patients (age from 0.3 to 28 year) and correlated with pulmonary function, pancreatic phenotype, pulmonary colonization and genotype severity.
Results
The CFTR-chloride conductance was better in older patients (r = 0.40; P = 0.03), in patients with better pulmonary function (r = 0.48; P = 0.01), and was associated with genotype severity. Higher chloride diffusion in the presence of a favorable chemical gradient was associated with Pseudomonas aeruginosa negativity (P < 0.05). More negative NPDmax was associated with pancreatic insufficiency (P < 0.01) as well with genotype severity, but not with the pulmonary function.
Conclusions
The anion permeability through CFTR, mainly chloride, but bicarbonate as well, is the most critical factor in CF airway pathophysiology. Treatments primarily directed to correct CFTR function and/or airway acidity are clearly a priority.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Cystic fibrosis (CF) is a recessive genetic disease caused by CF transmembrane conductance regulator (CFTR) gene mutations that encodes the CFTR protein [1]. CFTR protein is an epithelial ion channel that transports chloride (Cl−) and bicarbonate (HCO3−), and regulates other ion channels (namely sodium, potassium, other chloride and calcium channels). It also interacts with other membrane proteins to maintain epithelial tight-junctions and barriers to fluid flow. CFTR protein adjusts the levels of acidity in secretions that, along with fluid and chloride abnormalities, lead to some of the common manifestations of the CF clinical syndrome such as small airway disease and pancreatic insufficiency [2]. The disrupted ion transport also causes cell hyperpolarization or depolarization depending on whether the cell is secretory or absorptive, respectively [3].
Impairment of the mucociliary clearance (MCC) because of increased viscosity of the airway surface liquid (ASL) is thought to predispose CF patients to small airway disease with chronic airway infection, associated airway inflammation, progressive airway obstruction and lung injury [3,4,5,6]. How the dysfunctional CFTR leads to increased viscosity of ASL remains somewhat controversial since some researches hold that it is caused by deficient chloride secretion and excessive sodium and water reabsorption from the periciliar fluid [6] while other hold that it is caused by a lack of bicarbonate secretion with relative acidification of airway surface liquids [4].
Nasal potential difference (NPD) estimates the relative ion conductance based on transepithelial voltage (Vt) changes across nasal surface epithelial cells in vivo. The loss of CFTR-dependent anion conductance causes characteristic hyperpolarization, which is associated with a characteristic pattern of Vt changes in response to specific transport inhibitors and agonists [7, 8]. Recently, US and European NPD protocols were published with new and better quantitative and discriminatory parameters for using the NPD as a biomarker of CFTR function [9, 10].
In this study, we measured the NPD to correlate the in vivo CFTR-chloride transport in the nasal epithelium with CF pulmonary function and airway bacterial colonization. Secondarily, we analyzed the correlation with pancreatic phenotype, nutritional status, and genotype. Our results may help in further understanding of how abnormal anion transport is related to CF airway disease pathophysiology and help contribute to faster development of new and more effective treatments.
Methods
Study Subjects
CF patients in a clinically stable condition were recruited from the pediatric and adult CF Clinics of Hospital de Clínicas de Porto Alegre (HCPA) [1]. Subjects or their parents gave and signed a written informed consent. The study was reviewed and approved by the Ethical Review Board of HCPA and registered at HCPA Post-Graduation Research Group as number 05-125.
Data regarding age, sex and sweat chloride were collected from medical records. The pulmonary function was assessed as the percentage of predicted normal forced expiratory volume in one second (ppFEV1) and as the FEV1 z-score for age, sex and height for each individual subject measured by spirometry using the global lung function 2012 equation of the Global Lung Function Initiative [11]. Lung infection was defined as a single positive respiratory tract culture (throat, sputum, or bronchoalveolar lavage culture) within the previous six months for Pseudomonas aeruginosa (Pa) regardless of whether the subject cultured positive for other organisms. The pancreatic status (pancreatic insufficient (PI) or pancreatic sufficient (PS)) was evaluated based on need for pancreatic enzyme replacement therapy and/or on fecal elastase measurement. The nutritional status was assessed by the absolute body mass index (BMI) and BMI-for-age z-score. For patients older than 18 years of age, the BMI-for-age z-score of 18-year-old subjects was used as a reference.
CFTR genotype data included analyzes by Real Time-PCR of the 10 most frequent CFTR mutations in South Brazil (F508del, R347P, R347H, R334W, G542X, G551D, R553X, S549N, W1282X and N1303K) [12]. DNA sequencing was done in some patients if the PCR was negative. Each genotype was assigned to one of three groups according to the CFTR mutation, regardless of clinical features. The “severe” genotype group included patients with two mutations of class I, II, or III; the “mild” genotype group included patients with at least one mutation of class IV, V or VI, and the “unknown” genotype group included patients with no identified CFTR mutation or without an available CFTR genetic test. The CFTR mutations were assigned to classes based on the list provided by Elborn [1] and completed according to the genotype severity.
Nasal Potential Difference
NPD measurements were performed as previously described using the dermal abrasion NPD-method [13] under standardized conditions. After direct rhinoscopy to assess nasal epithelium integrity, absence of polyps, and nasal turbinate anatomy the most stable voltage measure under the inferior nasal turbinate after basal solution perfusion was recorded as the maximum NPD (NPD-max). Other NPD measurements were recorded at the end of 3 sequential phases of perfusion of each test solution as follows: (1) basal solution plus 100 μM amiloride (2) low-chloride plus 100 μM amiloride solution, and (3) low-chloride plus 100 μM amiloride plus 10 μM isoproterenol solution.
The following changes in NPD were recorded in response to: (1) amiloride (Δ-amil), which gives the response to blocking Na+ uptake through ENaC; (2) low-chloride plus amiloride solution (Δ-ØCl), which gives the Vt in response to a chloride gradient; (3) low-chloride plus amiloride plus isoproterenol solution (Δ-iso), which gives the Vt induced by isoproterenol via cAMP-mediated chloride conductance through CFTR. The sum of Δ-ØCl + Δ-iso was equivalent to the total chloride response (TCR). TCR was taken as the most sensitive and specific indicator of the CFTR-dependent chloride conductance, and therefore, as the activity of CFTR-chloride channel [14].
Statistical Analysis
Descriptive analyzes of categorical variables were presented as numerical and percentage (n (%)) values and of continuous variables as mean ± standard deviation (SD). Correlations were explored using Pearson’s rank correlation or Chi-Square coefficient, as appropriate. Comparisons between groups were tested by the T-test, nonparametric Mann–Whitney test or by ANOVA post-hoc multiple comparisons.
Analyzes were performed using SPSS 18.0 software. All P values were two-sided and considered significant if P < 0.05.
Results
The NPD was initially measured in 29 CF patients. One patient was excluded because the CF diagnosis was questioned. Another patient with a rare genotype (5 T–5 T) was retained because she demonstrates a classical phenotype including bronchiectasis, pancreatic insufficiency and sweat chloride > 60 mmol/L. The demographic data, the CFTR mutations, and NPD parameters of the CF patients are presented in Table 1. The NPD measurements according to pancreatic phenotype, Pseudomonas aeruginosa colonization, and genotype severity are presented in Table 2.
All patients demonstrated typical CF-NPD tracings with more negative NPD-max (− 35.14 ± 11.92 mV), raised Δ-amil (Δ-amil: 24.46 ± 10.38) and reduced TCR (TCR: − 1.82 ± 4.15) compared to our reference NPD parameters in normal controls (NPD-max − 15.00 ± 4.25 mV, Δ-amil: 6.35 ± 3.5 and TCR: 11.82 ± 3.05). The TCR ranged from 6 to − 10 mV and showed correlation with the age, being higher in older patients (r = 0.40; P = 0.03). No correlation was found between all NPD parameters and sweat chloride.
The TCR was also correlated with pulmonary phenotype. Better ppFEV1 and FEV1−z score were significantly correlated with a larger TCR (r = 0.48; P = 0.01 and r = 0.49; P < 0.01, respectively). However, after adjusting for age, the correlation between TCR and pulmonary function approached the limit of significance (r = 0.38; P = 0.05), which may be due to the small sample size. CFTR function was apparently not associated with Pa colonization. But Pa colonization appeared to be associated with Δ-ØCl: A more negative Δ-ØCl (− 2.50 mV) was observed in Pa-negative patients compared to Pa-positive patients (Δ-ØCl = 0.56) (P < 0.05). Neither was CFTR function associated with pancreatic phenotype, since both PS and PI patients showed residual CFTR function. No association was found between TCR and nutritional status.
The TCR appeared to reflect genotype severity, being smallest in the severe genotype group (− 0.80 ± 3.80), intermediately reduced in the unknown genotype group (− 2.43 ± 4.89) and largest in the mild genotype group (− 3.67 ± 3.04). However, the differences between the groups did not attain statistical significance in this small population.
NPD-max and the Δ-amil were not correlated with pulmonary function. Neither did they associate with airway Pa colonization. However, NPD-max appeared to reflect pancreatic phenotype. A significantly more negative NPD-max (− 38.57 ± 11.40 mV) (n = 21) was found in PI patients compared to PS patients (− 24.86 ± 4.19) (n = 7) (P < 0.01). No association was apparent between the pancreatic status and any other measured parameter (Table 2).
NPD-max was also correlated with genotype severity, being more negative in the severe genotype group (− 38.87 ± 13.92 mV), less negative in the mild genotype group (− 32.83 ± 7.41 mV) and least negative in the unknown genotype group (− 29.14 ± 7.14 mV). The difference was statistically significant between the severe and unknown group (P = 0.04) (Table 2).
Discussion
Our study showed that the in vivo CFTR-chloride transport in nasal epithelial cells in CF is correlated with better pulmonary function and confirmed that it is also related to genotype, representing a continuous spectrum associated with the genotype severity, appearing lower in patients with two severe CFTR mutations and higher in patients with milder genotype. Our study also showed that CFTR-chloride conductance is strongly associated with pancreatic insufficiency. An interesting finding was the association between Pa with the cellular chloride diffusion through non-CFTR channels.
The cellular basis as well as the precise transport pathways of electrolyte and fluid, absorption and secretion, in the airways are still not well established nor are the primary mechanisms whereby defective CFTR leads to CF airway disease [2, 3, 15,16,17,18]. The normal airway epithelium apparently consists of both absorptive and secretory cells whereby fluid and electrolyte transport are balanced across airway epithelia to regulate and maintain homeostasis of the ASL and support efficient MCC [17]. But maintenance of the alkaline ASL-pH based on bicarbonate secretion via CFTR or calcium-activated chloride channel-dependent (CaCCs) is also critical for normal MCC. In CF, the ASL is both more viscous as well as more acidic, impairing the airway MCC and causing mucus retention, airway inflammation, infection, and pulmonary destruction [3,4,5]. Our results indicate that residual CFTR-chloride conductance is associated with better pulmonary function. Unfortunately, we lack data to correlate CFTR-chloride conductance with structural lung damage, sputum rheology, or MCC measurements. Even though we only assessed the relative CFTR-chloride conductance, it seems possible, if not likely, that the CFTR-bicarbonate transport is affected or spared similarly, which would imply that increased residual CFTR-chloride conductance as well as increased residual CFTR-bicarbonate secretion underlie better clinical outcomes in CF disease.
Pseudomonas aeruginosa is perhaps the most important pathogen in CF lung infection and often associated with more rapid decline in pulmonary function [1, 5]. We found no association between CFTR-chloride conductance with Pa. But, interestingly, we found an association between the magnitude of NPD response to the low-chloride plus amiloride solution-NPD (Δ-ØCl) with Pa infection. The Δ-ØCl represents the chloride diffusion that occurs because of a large chemical gradient generated by a chloride-free solution besides sodium conductance blocking caused by the amiloride. This chloride movement represents mainly the chloride conductance across alternative chloride channels, such as the CaCCs, which also transport bicarbonate [7,8,9], besides the chloride transport across CFTR. So, it could be possible that maintenance of chloride and bicarbonate transport across alternative channels is involved in bacterial airway clearance, mainly Pa. Of course, our small sample size limits the significance of this finding, which has to be better studied. Others studies that analyzed the relationship between NPD and Pa infection did not find similar result [19,20,21,22], but a study by Green et al. described an association between residual CFTR function, predicted by the class of CFTR mutation, with delayed acquisition of multiple respiratory pathogens in CF, including Pseudomonas aeruginosa [23]. In our study, however, no association was found between Pa and genotype severity.
The relationship between NPD and CFTR mutations has been reported for men with congenital bilateral absence of the vas deferens and subjects with non-cystic fibrosis bronchiectasis when used as a diagnostic approach [14, 20]. Wilschanski et al. [14] and Bienvenu et al. [24] reported that the NPD correlates with the number and the severity of the CFTR mutations in atypical CF cases. Our study confirmed that this relationship is also present in a within population of typical CF patients and that shows a pattern of continuity based in genotype severity. The association was demonstrated even though the genotype was unknown in 7 patients, a situation that is not unusual in CF because even extensive mutation analysis may fail to identify mutations in about 4% of patients having a conventional diagnosis of CF [1].
Pancreatic sufficiency is usually associated with better nutritional status and milder pulmonary disease in CF [1], but this association was not seen in our patients. Neither did we find a correlation between PS and residual CFTR-chloride conductance. Similarly, we did not find an association between nutritional condition and CFTR-chloride conductance. The association we found was between PS pancreatic sufficiency and lower cellular hyperpolarization (NPD-max). Initially, the NPD-max was considered as a measure of the upregulated sodium absorption through ENaC that was not inhibited by lack of CFTR function in CF airways [7]. Recent studies in primary cultures of tracheal/bronchial CF epithelia did not confirm that the sodium absorption is increased in CF and the more negative NPD-max was attributed to the loss of anion transport [25]. Thus, the magnitude of the NPD-max seems to be due essentially to the loss of anion conductance, chloride and bicarbonate, and not sodium hyperabsorption. So, based on these results, the defect in CFTR anion conductance is critical in determining pancreatic insufficiency, since bicarbonate is the major anion driving pancreatic duct fluid secretion [26]. Moreover, the pancreas is not known to absorb Na+ or express ENaC [26]. However, previous studies on NPD and CF pancreatic phenotype reported a correlation of residual CFTR function with pancreatic sufficiency [27, 28]. Nonetheless, our results may suffer from a lack of methods that yield a more quantitative evaluation of the pancreatic function in all patients, such as fecal elastase or the fecal fat measurements. Hence, minor malabsorption related to pancreatic insufficiency may not been diagnosed.
The limitations in this study include: (i) The small number of subjects limited solid comparisons between some groups, although sufficient sample size for correlation analysis had been determined. (ii) We used the dermal abrasion NPD-method instead of the subcutaneous reference electrode as suggested by ECFS–NPD–SOP or CFF–TDN–SOP guidelines [9, 10, 13]. We used a dermal abrasion because it was validated in our institution and because of the operator’s expertise. De Watcher et al. reported both methods are similar and acceptable suggesting that the operators preferred NPD-method should be used [29]. (iii) The final NPD step with an ATP-solution was not performed. ATP was not available in our laboratory, and we felt that this step is used more as a quality control to confirm the epithelial integrity rather than having essential diagnostic value.
In summary, in vivo less or no anion CFTR-conductance appears to be correlated with CF pulmonary and pancreatic disease. Thus, the CFTR function is the principal factor in CF airway disease pathogenesis and involves anions, chloride and bicarbonate. New therapeutics directed to correct the CFTR- anion conductance and/or the airway acidity are essential in CF, although further studies to elucidate the conductance of chloride and bicarbonate throughout CFTR or alternative channels like CaCCs are needed. Meanwhile, treatments directed to hydrate the airway and improve MCC or correct ASL-pH remain justified.
References
Elborn JS (2016) Cystic fibrosis. Lancet 388:2519–2531
Liou TG (2019) The clinical biology of cystic fibrosis transmembrane regulator protein: its role and function in extrapulmonary disease. Chest 155(3):605–616
Quinton PM (2017) Both ways at once: keeping small airways clean. Physiology (Bethesda) 32(5):380–390
Tang XX, Ostedgaard LS, Hoegger MJ, Moninger TO, Arp PH, McMenimen JD et al (2016) Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest 126:879–891
Rubin BK (2018) Unmet needs in cystic fibrosis. Expert Opin Biol Ther 8:49–52
Garland AL, Walton WG, Coakley RD, Tan CD, Gilmore RC, Hobbs CA et al (2013) Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci USA 110(40):15973–15978
Knowles MR, Paradiso AM, Boucher RC (1995) In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 6:445–455
Middleton PG, Geddes DM, Alton EWFW (1994) Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J 7:2050–2056
Solomon GM, Konstan MW, Wilschanski M, Billing J, Sermet-Gaudelus I, Accurso F et al (2010) An international randomized multicentre comparison of nasal potential difference techniques. Chest 138:919–928
Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, et al. on behalf of the ECFS Diagnostic Network Working Group (2014) Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey. J Cyst Fibr 13: 24–28.
Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, the ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function, et al (2012) equations. Eur Respir J. 2012(40):1324–1343
Streit C, Burlamaque-Neto AC, Abreu e Silva F, Giugliani R, MLS, Pereira, MLS (2003) CFTR gene: molecular analysis in patients from South Brazil. Mol Genet Metab 78:259–264
Leal T, Lebacq J, Lebecque P, Cumps J, Wallemacq P (2003) Modified method to measure nasal potential difference. Clin Chem Lab Med 41(1):81–87
Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E et al (2006) Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Respir Crit Care Med 174:787–794
Frizzel RA, Hanrahan JW (2012) Physiology of epithelial chloride and fluid secretion. Cold Spring Harb Perspect Med 2:a009563
Althaus M (2013) ENaC Inhibitors and airway Re-hydration in cystic fibrosis: state of the art. Curr Mol Pharmacol 6:3. https://doi.org/10.2174/18744672112059990025
Borowitz D (2015) CFTR, bicarbonate, and the pathophysiology of cystic fibrosis. Pediatr Pulmonol 50:S24–S30
Fernandez EF, de Santi C, de Rose V, Greene CM (2018) CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease. Expert Rev Respir Med 12(6):483–492
Fajac I, Hubert D, Bienvenu T, Richaud-Thiriez B, Matran R, Kaplan J-C, D et al (1998) Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis. Eur Respir J 12:1295–1300
Thomas SR, Jaffe A, Geddes DM, Hodson ME, Alton EWFW (1999) Pulmonary disease severity in men with delta F508 cystic fibrosis and residual chloride secretion. Lancet 353:984–985
Leal T, Fajac I, Wallace HL, Lebecque P, Lebacq J, Hubert D et al (2008) Airway ion transport impacts on disease presentation and severity in cystic fibrosis. Clin Biochem 41:764–772
Simmonds NJ, D’Souza L, Roughton M, Alton EWFW, Davies JC, Hodson ME (2011) Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane regulator function. Eur Respir J 37:1076–1082
Green DM, McDougal KE, Blackman SM, Sosnay PR, Henderson LB, Naughton KM et al (2010) Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res 11:140
Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L et al (2010) Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 181(10):1078–1084
Itani OA, Chen J-H, Karp PH, Ernst S, Keshavjee S, Parekh K, Klesney-Tait J et al (2011) Human cystic fibrosis airway have reduced Cl− conductance but not increased Na+ conductance. Proc Natl Acad Sci USA 108(25):10260–10265
Quinton PM (2010) Role of epithelial HCO3- transport in mucin secretion lessons from cystic fibrosis. Am J Physiol Cell Physiol 299(6):C1222–C1233
Ho LP, Samways JM, Porteous DJ, Dorin JR, Carothers A, Greening AP et al (1997) Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis. Eur Respir J 10:2018–2022
Fajac I, Hubert D, Guillemot D, Honoré I, Nu T, Volter F et al (2004) Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax 59:971–976
De Wachter E, De Schutter I, Meulemans A, Buyl R, Malfroot A (2016) A semi-blinded study comparing 2 methods of measuring nasal potential difference: Subcutaneous needle versus dermal abrasion. J Cyst Fibr 15:60–66
Acknowledgements
We thank Dr. Teresinha Leal from Louvain Centre for Toxicology and Applied Pharmacology, Universite Catholique de Louvain, Brussels, Belgium, for her assistance on training of nasal potential difference protocol measurement.
Funding
This work was supported by the Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre (FIPE-HCPA).
Author information
Authors and Affiliations
Contributions
EFAP and FAAS design the study. FAAS, PJCM and PMQ provided critical evaluation of methods, results and conclusions. EFAP wrote the manuscript with critique by PJCM and PMQ.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest related to this work.
Informed Consent
All subjects or their parents gave and signed a written informed consent. The study was reviewed and approved by the Ethical Review Board of HCPA and registered at HCPA Post-Graduation Research Group as number 05-125.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Procianoy, E.F.A., de Abreu e Silva, F.A., Maróstica, P.J.C. et al. Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology. Lung 198, 151–156 (2020). https://doi.org/10.1007/s00408-019-00293-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-019-00293-6